Targeting ribonucleotide reductase to enhance the antileukemic activity of gilteritinib against chemoresistant FLT3- internal tandem duplication acute myeloid leukemia

ASPET Discovery · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles